Unorthodoxically, this study in NSCLC and the previous studies of JAK1 in uterine cancer [21–23] also suggest that JAK1 and JAK2 have tumor suppressor function, deficiencies of them could allow tumor cells to escape T-cell mediated immune surveillance. The gene discussed is JAK2; the disease is non-small cell lung carcinoma.